Merck signs $1.2 billion deal with US government for ... - ABC News
2021年6月9日 · The United States government has agreed to purchase $1.2 billion worth of an experimental COVID-19 treatment from Merck if the drug is approved by regulators, the pharmaceutical company announced Wednesday. This purchase would provide enough medication to fully treat 1.7 million people with the new drug.
Merck and Ridgeback Announce U.S. Government to Purchase …
2021年11月9日 · KENILWORTH, N.J. & MIAMI-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United States government will exercise two of its options to purchase a total of 1.4 million additional courses of molnupiravir, an investigational oral antiviral medicine, if t...
U.S. government to buy $1 billion more worth of Merck's COVID-19 pill
2021年11月9日 · The U.S. government will buy another $1 billion worth of the COVID-19 pill made by Merck & Co Inc and partner Ridgeback Biotherapeutics, the companies said on Tuesday.
Merck: US to buy 1.4M more doses of COVID-19 pill - The Hill
2021年11月9日 · Merck, together with Ridgeback Biotherapeutics, announced early Tuesday that the U.S. government is set to purchase an additional 1.4 million courses of the companies’ antiviral COVID-19...
U.S. Inks $1 Billion Deal For Extra Doses Of Merck’s ... - Forbes
2021年11月9日 · The U.S. government has purchased an additional 1.4 million courses of Merck’s antiviral Covid-19 pill, the company announced Tuesday, almost doubling the country’s stockpile as nations...
US to procure 1.4 million courses of Merck’s Covid-19 pill for $1bn
2021年11月10日 · The US Government will buy 1.4 million courses of Merck (MSD) and Ridgeback Biotherapeutics’ molnupiravir for nearly $1bn. This purchase is pursuant to obtaining emergency use authorization (EUA) or approval from the US Food and Drug Administration (FDA) for the experimental antiviral pill to treat Covid-19.
Merck Announces Supply Agreement with U.S. Government for …
2021年6月9日 · Through the agreement, if molnupiravir receives Emergency Use Authorization (EUA) or approval by the U.S. Food and Drug Administration (FDA), Merck will receive approximately $1.2 billion to supply approximately 1.7 million courses of molnupiravir to the United States government.
U.S. to buy $1 billion worth of Merck's antiviral COVID pill - Axios
2021年11月9日 · The Biden administration will buy 1.4 million additional courses of a pill developed by Merck and Ridgeback Biotherapeutics to prevent or treat COVID-19, a purchase worth around $1 billion, the companies announced Tuesday.
US to buy 1.4M more Merck COVID antiviral pills for $1B
The U.S. government has agreed to purchase 1.4 million more courses of molnupiravir, Merck's experimental COVID-19 antiviral drug, for roughly $1 billion, the drugmaker said Nov. 9.
US to buy 1.7 million courses of Merck's COVID pill - Medical Xpress
2021年6月9日 · The United States on Wednesday announced an agreement with Merck to buy 1.7 million courses of an experimental antiviral pill against COVID-19. The $1.2 billion dollar deal is for a drug...